Ironwood Pharmaceuticals, Inc.
IRWD
$3.58
-$0.09-2.45%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 220.47M | 215.46M | 140.41M | 92.85M | 108.48M |
| Total Receivables | 105.84M | 46.75M | 120.37M | 86.17M | 39.77M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.98M | 11.98M | 13.07M | 12.73M | 12.33M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 332.29M | 274.18M | 273.84M | 191.75M | 160.58M |
|
|
|||||
| Total Current Assets | 332.29M | 274.18M | 273.84M | 191.75M | 160.58M |
| Net Property, Plant & Equipment | 12.06M | 12.75M | 13.44M | 14.13M | 14.88M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.84M | 2.04M | 2.25M | 2.45M | 2.66M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 88.37M | 107.94M | 106.53M | 134.61M | 149.10M |
| Total Assets | 434.57M | 396.90M | 396.06M | 342.95M | 327.21M |
|
|
|||||
| Total Accounts Payable | 3.24M | 2.90M | 1.61M | 1.39M | 5.83M |
| Total Accrued Expenses | 13.31M | 19.18M | 19.57M | 17.27M | 16.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 203.12M | 202.93M | 202.74M | 202.55M | 3.20M |
| Total Finance Division Other Current Liabilities | 16.64M | 17.21M | 18.58M | 11.32M | 22.40M |
| Total Other Current Liabilities | 16.64M | 17.21M | 18.58M | 11.32M | 22.40M |
| Total Current Liabilities | 236.31M | 242.22M | 242.50M | 232.53M | 48.10M |
|
|
|||||
| Total Current Liabilities | 236.31M | 242.22M | 242.50M | 232.53M | 48.10M |
| Long-Term Debt | 385.00M | 385.00M | 385.00M | 385.00M | 584.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.23M | 9.87M | 10.50M | 11.12M | 11.72M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 21.17M | 21.65M | 22.22M | 22.47M | 17.29M |
| Total Liabilities | 651.71M | 658.74M | 660.22M | 651.11M | 661.27M |
|
|
|||||
| Common Stock & APIC | 1.42B | 1.41B | 1.41B | 1.41B | 1.40B |
| Retained Earnings | -1.63B | -1.67B | -1.67B | -1.71B | -1.74B |
| Treasury Stock & Other | -795.00K | -1.06M | -1.71M | -2.03M | 294.00K |
| Total Common Equity | -217.14M | -261.84M | -264.16M | -308.16M | -334.05M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -217.14M | -261.84M | -264.16M | -308.16M | -334.05M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -217.14M | -261.84M | -264.16M | -308.16M | -334.05M |
|
|
|||||